Project information
Sekvenční FDG-PET a miRNA jako biomarker změny strategie předoperační léčby u lokálně pokročilého karcinomu žaludku a gastroesofageální junkce
- Project Identification
- 17-29389A (kod CEP: NV17-29389A)
- Project Period
- 4/2017 - 12/2020
- Investor / Pogramme / Project type
-
Ministry of Health of the CR
- Ministry of Health Research Programme 2015 - 2022
- MU Faculty or unit
- Central European Institute of Technology
- Cooperating Organization
-
Masaryk Memorial Cancer Institute Brno
- Responsible person prof. MUDr. Rostislav Vyzula, CSc.
Sekvenční FDG-PET a miRNA jako biomarker změny strategie předoperační léčby u lokálně pokročilého karcinomu žaludku a gastroesofageální junkce
Publications
Total number of publications: 3
2020
-
Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002–2017)
Journal of Pediatric Gastroenterology and Nutrition, year: 2020, volume: 70, edition: 5
2019
-
High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impact
European Journal of Cancer, year: 2019, volume: 116, edition: JUL 2019, DOI
2018
-
Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population
Anticancer Research, year: 2018, volume: 38, edition: 6, DOI